CRNX
NASDAQ · Pharmaceuticals
Crinetics Pharmaceuticals In
$34.37
-0.34 (-0.98%)
Performance
1D
—
1W
—
1M
—
3M
-28.34%
6M
-25.14%
1Y
-2.00%
YTD
-26.45%
Open$34.02
Previous Close$34.71
Day High$34.77
Day Low$33.49
52W High$57.99
52W Low$24.10
Volume—
Avg Volume1.16M
Market Cap3.90B
P/E Ratio—
EPS$-4.94
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.40
Below
SMA 200
$38.81
Below
RSI (14)
27.9
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+43.7% upside
Current
$34.37
$34.37
Target
$49.40
$49.40
$38.77
$49.40 avg
$74.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.50M | 7.23M | 1.14B |
| Net Income | -514,267,576 | -393,806,533 | 346.78M |
| Profit Margin | -6,046.2% | -5,743.9% | 30.3% |
| EBITDA | -567,220,337 | -458,486,616 | 475.78M |
| Free Cash Flow | — | — | 205.84M |
| Rev Growth | +17.5% | +17.5% | +24.5% |
| Debt/Equity | — | — | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |